Herschorn, Sender, Jameel Nazir, Barbara Ramos, and Zalmai Hakimi. 2017. “Supplementary Data: Cost-Effectiveness of Mirabegron Compared to Tolterodine ER 4 Mg for Overactive Bladder in Canada”. Canadian Urological Association Journal 11 (3-4):E129-33. https://doi.org/10.5489/cuaj.4617.